Literature DB >> 31945016

Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis.

Jeongeun Hyun1,2,3, Zhaoli Sun4, Ali Reza Ahmadi4, Sushant Bangru5,6, Ullas V Chembazhi5, Kuo Du1, Tianyi Chen7, Hidekazu Tsukamoto8,9, Ivan Rusyn10, Auinash Kalsotra5,6,11, Anna Mae Diehl1.   

Abstract

Severe alcoholic hepatitis (SAH) is a deadly liver disease without an effective medical therapy. Although SAH mortality is known to correlate with hepatic accumulation of immature liver cells, why this occurs and how it causes death are unclear. Here, we demonstrate that expression of epithelial splicing regulatory protein 2 (ESRP2), an RNA-splicing factor that maintains the nonproliferative, mature phenotype of adult hepatocytes, was suppressed in both human SAH and various mouse models of SAH in parallel with the severity of alcohol consumption and liver damage. Inflammatory cytokines released by excessive alcohol ingestion reprogrammed adult hepatocytes into proliferative, fetal-like cells by suppressing ESRP2. Sustained loss of ESRP2 permitted reemergence of a fetal RNA-splicing program that attenuates the Hippo signaling pathway and thus allows fetal transcriptional regulators to accumulate in adult liver. We further showed that depleting ESRP2 in mice exacerbated alcohol-induced steatohepatitis, enabling surviving hepatocytes to shed adult hepatocyte functions and become more regenerative, but threatening overall survival by populating the liver with functionally immature hepatocytes. Our findings revealed a mechanism that explains why liver failure develops in patients with the clinical syndrome of SAH, suggesting that recovery from SAH might be improved by limiting adult-to-fetal reprogramming in hepatocytes.

Entities:  

Keywords:  Cell Biology; Cytokines; Hepatology; Molecular pathology; RNA processing

Mesh:

Substances:

Year:  2020        PMID: 31945016      PMCID: PMC7108908          DOI: 10.1172/JCI132691

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  77 in total

Review 1.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

Review 2.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

3.  Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark.

Authors:  Nikolaj Worm Orntoft; Thomas Damgaard Sandahl; Peter Jepsen; Hendrik Vilstrup
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-26       Impact factor: 11.382

Review 4.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Authors:  Keisaku Sato; Marco Marzioni; Fanyin Meng; Heather Francis; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

Review 5.  Coagulation in liver disease: a guide for the clinician.

Authors:  Patrick G Northup; Stephen H Caldwell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-16       Impact factor: 11.382

Review 6.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

7.  Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis.

Authors:  Beatriz Aguilar-Bravo; Daniel Rodrigo-Torres; Silvia Ariño; Mar Coll; Elisa Pose; Delia Blaya; Isabel Graupera; Luis Perea; Júlia Vallverdú; Teresa Rubio-Tomás; Laurent Dubuquoy; Carolina Armengol; Antonio Lo Nigro; Peter Stärkel; Philippe Mathurin; Ramon Bataller; Joan Caballería; Juan José Lozano; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2019-03-12       Impact factor: 17.298

8.  Dysregulated activation of fetal liver programme in acute liver failure.

Authors:  Jeongeun Hyun; Seh-Hoon Oh; Richard T Premont; Cynthia D Guy; Carl L Berg; Anna Mae Diehl
Journal:  Gut       Date:  2019-01-22       Impact factor: 31.793

9.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nucleic Acids Res       Date:  2008-11-25       Impact factor: 16.971

Review 10.  Survival from alcoholic hepatitis has not improved over time.

Authors:  Emily Hughes; Laurence J Hopkins; Richard Parker
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

View more
  17 in total

Review 1.  Alternative splicing of lncRNAs in human diseases.

Authors:  Jiaxi Chen; Yawen Liu; Jingyu Min; Huizhi Wang; Feifan Li; Chunhui Xu; Aihua Gong; Min Xu
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Current Management and Future Treatment of Alcoholic Hepatitis.

Authors:  Mack C Mitchell; Thomas Kerr; H Franklin Herlong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 3.  Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression.

Authors:  Ying Liu; Yiwen Li; Chengcheng Du; Shouxiang Kuang; Xuehao Zhou; Jinyu Zhang; Xiang Ao
Journal:  J Mol Med (Berl)       Date:  2022-09-27       Impact factor: 5.606

4.  Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.

Authors:  Peter S Harris; Cole R Michel; Youngho Yun; Courtney D McGinnis; Mohammed A Assiri; Ali Reza Ahmadi; Zhaoli Sun; James R Roede; Matthew A Burchill; David J Orlicky; Rebecca L McCullough; Kristofer S Fritz
Journal:  Alcohol       Date:  2021-12-17       Impact factor: 2.558

Review 5.  Hepatic Regeneration in Cirrhosis.

Authors:  Ankur Jindal; Rakesh K Jagdish; Anupam Kumar
Journal:  J Clin Exp Hepatol       Date:  2021-09-04

6.  Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis.

Authors:  Josiah Hardesty; Le Day; Jeffrey Warner; Dennis Warner; Marina Gritsenko; Aliya Asghar; Andrew Stolz; Timothy Morgan; Craig McClain; Jon Jacobs; Irina Kirpich
Journal:  Am J Pathol       Date:  2022-04-28       Impact factor: 5.770

7.  Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.

Authors:  Jeongeun Hyun; Muthana Al Abo; Rajesh Kumar Dutta; Seh Hoon Oh; Kun Xiang; Xiyou Zhou; Raquel Maeso-Díaz; Rebecca Caffrey; Arun J Sanyal; Jennifer A Freedman; Steven R Patierno; Cynthia A Moylan; Manal F Abdelmalek; Anna Mae Diehl
Journal:  J Hepatol       Date:  2021-05-06       Impact factor: 30.083

Review 8.  Alternative Splicing in Hepatocellular Carcinoma.

Authors:  Seung Eun Lee; Karel P Alcedo; Hong Jin Kim; Natasha T Snider
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-05-08

Review 9.  MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.

Authors:  Na-Hyun Lee; So Jung Kim; Jeongeun Hyun
Journal:  Biomedicines       Date:  2021-03-30

10.  Gene Deconvolution Reveals Aberrant Liver Regeneration and Immune Cell Infiltration in Alcohol-Associated Hepatitis.

Authors:  Adam Kim; Xiaoqin Wu; Daniela S Allende; Laura E Nagy
Journal:  Hepatology       Date:  2021-06-15       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.